GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Tax Expense

AlzChem Group AG (XTER:ACT) Tax Expense : €15.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Tax Expense?

AlzChem Group AG's tax expense for the months ended in Mar. 2024 was €5.0 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2024 was €15.3 Mil.


AlzChem Group AG Tax Expense Historical Data

The historical data trend for AlzChem Group AG's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Tax Expense Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.35 7.33 8.75 11.06 13.40

AlzChem Group AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.06 2.74 3.38 4.22 4.98

AlzChem Group AG Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzChem Group AG  (XTER:ACT) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


AlzChem Group AG Tax Expense Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (XTER:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (XTER:ACT) Headlines

From GuruFocus

Enact Announces an Increase to Quarterly Dividend

By sperokesalga sperokesalga 05-01-2023

Enact Announces Neenu Kainth as Chief Customer Experience Officer

By GlobeNewswire GlobeNewswire 08-22-2022

Enact Welcomes Jerome Upton to its Board of Directors

By sperokesalga sperokesalga 03-02-2023

Enact Receives Ratings Upgrade from Moody's

By sperokesalga sperokesalga 03-01-2023

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023

Enact Receives Ratings Upgrade from S&P Global Ratings

By sperokesalga sperokesalga 02-16-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By GlobeNewswire GlobeNewswire 01-06-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By Stock market mentor Stock market mentor 01-06-2023